Unpacking the Federal Drug Price Reduction Struggle
How Political Rhetoric and Behind-the-Scenes Deal-Making Obscure Who Really Pays – or How Much
Blog Post
The United States’ food policy is at a pivotal moment. We now have a chance to remove ultra-processed foods, the nutrient-poor “foods” made of lab-made chemicals and engineered to be addictive, from dinner plates and grocery store shelves.
Even with support from the “Make Our Children Healthy Again” report, this will take policy change at all levels. Local efforts are critical, particularly in schools. Pediatricians can inspire children and families to exercise their consumer power and buy fresh, whole foods instead of ultra-processed chips, soda, chicken nuggets, and the like.
We suggest three policies to reduce ultra-processed food consumption by children and promote a healthier food environment for all Americans.
Given how firms can declare food additives safe with no pre-market FDA approval through the federal “generally recognized as safe” or GRAS loophole, and the length of time it takes to change regulations on the federal level, state-level restrictions on potentially harmful food additives can fill federal gaps. Recently, several states have restricted common food additives, including brominated vegetable oil, potassium bromate, propylparaben, and Red #3, and similar legislation is pending in more than 20 states.
The U.S. must adopt an easily understood food labeling system to communicate the effects of ultra-processed products and the overall healthfulness of whole foods to allow for strict regulation.
Food marketing to children is exploitative. Research has found that young children’s food preferences can be influenced by the presence of cartoon characters on packaging. Given the potential to manipulate children’s dietary choices, UNICEF (United Nations International Children’s Emergency Fund) has found that food marketing violates their human rights.
The article “Decreasing Children’s Consumption of Ultra-Processed Foods: A Policy Roadmap” was published October 24, 2025 in Pediatrics Open Science by Deniz Cataltepe and Senbagam Virudachalam.


How Political Rhetoric and Behind-the-Scenes Deal-Making Obscure Who Really Pays – or How Much
Even With Lower Prices, Medicare, Medicaid, and Other Insurers Tighten Coverage for Drugs Like Mounjaro and Zepbound Using Prior Authorization and Other Tools
Guidelines Matter, but Lasting Health Requires Investment in Better Food, More Activity, and More Targeted Tools From Medicaid and SNAP
A Wharton–Netter Center Collaboration Uses Experiential Learning to Build a Health Care Workforce Pipeline
Cheaper Housing Could be a Way to Lower Hospitalizations Among Medicaid Patients with Heart Failure
An LDI Expert Connects Nurse Wellbeing and Staffing to Patient Safety Outcomes